New Transcription Factors and Their Role in Diabetes and Therapy, 1st Edition,Jacob Friedman,ISBN9780444511584
Add to Wish List
 
 
 

Volume 5: New Transcription Factors and Their Role in Diabetes and Therapy, 1st Edition

Advances in Molecular and Cellular Endocrinology

Print Book

Editor : J Friedman  

Release Date:

Imprint: Elsevier Science

ISBN: 9780444511584

Pages: 332

Dimensions: 240 X 165

Buy print & eBook together
and save 40%

USD 139.95
Print Book

+

USD 139.95
eBook

USD 279.90Normal price

USD 167.94Bundle price

Add to Cart
Select format

Print Book Estimated Delivery Time

Hardcover

USD 139.95
USD 69.98

In Stock

eBook Subscription Subscription Details

USD 109.33

Subscription eBook - Science Direct (access for 5 users)

eBook eBook Overview

USD 139.95
USD 69.98

PDF format

VST format

Add to Cart

Buy Print & eBook both and save 40%
View Bundle Price

 
 

Description

This book contains contributions from some of the most eminent experts in the fields of genetics, biochemistry, and pathophysiology of diabetes. Through specific examples, with broad applications, this book provides a comprehensive look at how transcription factors may underline the pathogenetic mechanisms of diabetes and obesity.

Volume 5 provides an overview of the status of the field, while also providing valuable information of practical utility to those who do not necessarily work in this field. The integration of basic biology with physiologically and clinically relevant proteins should provide the reader with a theoretical background to understanding the strategies for new potential therapeutic targets and their application to disease.

Readership

Endocrinologists, Biomedical researchers, Geneticists, Molecular and Cellular Biologists

Jacob Friedman

Affiliations and Expertise

University of Colorado Health Sciences Center, Denver, CO, USA

New Transcription Factors and Their Role in Diabetes and Therapy, 1st Edition

1. PPARs as therapeutic targets for treating diabetes and insulin resistance
2. Genetic regulators of human obesity and diabetes
3. NF-kb, insulin resistance and the actions of salicylates
4. Wnt signaling and C/EBPs role in adipogenesis
5. Regulation of hepatic gluconeogenesis C/EPBs
6. Forkhead proteins and regulation of hepatic gene expression
7. Control of mitochondrial biogenesis through PGC-1
8. Regulation of PGC-1 in humans in insulin resistance and diabetes: Functional implications
9. FOXC2 controls resistance to obesity and Type II diabetes
10. SREB-1C regulation of nutrient homeostasis and lipid accumulation
11. GATA proteins as molecular gatekeeprs of the adipocyte
12. Diabetes regulation of gene expression by CREB
13. Molecular etiologies of MODY and other early-onset forms of diabetes
14. Liver X receptors as potential drug targets for Diabetes and its disorders
15. The potential therapeutic use of PPAR beta/delta agonists in lipid and glucose homeostasis
16. Influences of new PPAR insulin sensitizers on the metabolic syndrome in Rhesus Monkeys
17. PPARgamma and metabolism: Insights from the study of human genetic variants
»
New Transcription Factors and Their Role in Diabetes and Therapy
 

Related Products

Thyroid Neoplasms, 1st Edition

Print Book:
USD 139.95 USD 69.98
Editor: Boris Draznin
Release Date: 21 May 2005